A federal judge’s recent ruling striking down U.S. Food and Drug Administration (FDA) approval of abortion pill mifepristone is not likely to survive on appeal, legal experts told The Epoch Times.
The court decision is one of many to have followed across the country in the wake of the Supreme Court’s decision in June 2022 in Dobbs v. Jackson Women’s Health Organization, which overturned Roe v. Wade and found there was no right to abortion in the U.S. Constitution.
